What adjustments should be made to the insulin regimen of a 22-year-old female with type 1 diabetes mellitus on insulin lispro (Humalog) and insulin glargine (Lantus), with an HbA1c of 12.8% and hyperglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Aggressive Insulin Intensification Required

This patient requires immediate and aggressive insulin intensification with both basal and prandial insulin, as an HbA1c of 12.8% with glucose of 359 mg/dL represents severe uncontrolled hyperglycemia that warrants basal-bolus therapy from the outset. 1

Critical Assessment of Current Regimen

The current regimen is grossly inadequate:

  • Total daily insulin dose: Only 28 units/day (12 units lispro + 16 units Lantus)
  • Weight-based calculation: For a 22-year-old female (estimated ~60-70 kg), this represents approximately 0.4-0.47 units/kg/day
  • At HbA1c 12.8%, guidelines recommend starting doses of 0.5-1.0 units/kg/day for type 1 diabetes 1
  • This patient likely needs 30-70 units/day total to achieve adequate control 1

Immediate Treatment Plan

1. Aggressive Basal Insulin Titration

Increase Lantus by 4 units every 3 days until fasting glucose reaches 80-130 mg/dL 1

  • Current dose: 16 units daily
  • Target fasting glucose: 80-130 mg/dL 1
  • With fasting glucose ≥180 mg/dL (likely given HbA1c 12.8%), increase by 4 units every 3 days 1
  • Do not stop escalating until fasting glucose is consistently controlled 1

2. Intensify Prandial Insulin Coverage

The current 4 units TID lispro is insufficient - this needs immediate adjustment:

  • Increase each meal dose by 2-4 units immediately 1
  • Titrate prandial insulin by 1-2 units or 10-15% every 3 days based on 2-hour postprandial glucose readings 1
  • Target postprandial glucose: <180 mg/dL 1
  • For type 1 diabetes, approximately 50% of total daily dose should be prandial insulin 1

3. Expected Total Daily Dose

For adequate control at this HbA1c level:

  • Total daily insulin requirement: 0.5-1.0 units/kg/day 1
  • Split approximately 40-50% basal (Lantus) and 50-60% prandial (lispro) 1
  • For a 60 kg patient: 30-60 units/day total
  • For a 70 kg patient: 35-70 units/day total

Critical Monitoring Requirements

Daily self-monitoring of blood glucose is essential during this intensive titration phase 2:

  • Check fasting glucose every morning 1
  • Check pre-meal glucose before each meal 1
  • Check 2-hour postprandial glucose to guide prandial insulin adjustments 1
  • Reassess HbA1c every 3 months during intensive titration 1

Expected Outcomes

With appropriate basal-bolus therapy at weight-based dosing, HbA1c reduction of 3-4% is achievable over 3-6 months 1:

  • Expected HbA1c after 3-6 months: 8.8-9.8% (still requiring further optimization)
  • 68% of patients achieve mean blood glucose <140 mg/dL with proper basal-bolus therapy 1

Essential Patient Education

Comprehensive education is critically important 1:

  • Proper insulin injection technique and site rotation 2
  • Recognition and treatment of hypoglycemia - carry at least 15g carbohydrate at all times 2
  • Treat any glucose <70 mg/dL immediately with 15 grams of fast-acting carbohydrate 1
  • Self-monitoring of blood glucose technique 2
  • "Sick day" management rules - continue insulin even if unable to eat 2
  • Insulin storage and handling 1
  • Medical identification (bracelet or wallet card) 2

Critical Pitfalls to Avoid

Never delay aggressive insulin intensification in patients with HbA1c >10% 1:

  • Prolonged severe hyperglycemia (months at HbA1c >9%) should be specifically avoided due to increased risk of complications 3
  • Do not rely on sliding scale insulin alone - this is explicitly condemned by all major diabetes guidelines 1
  • Do not wait weeks between dose adjustments - adjust every 3 days during active titration 1
  • If hypoglycemia occurs, reduce the corresponding dose by 10-20% immediately 1

Special Consideration: Injection Technique Review

Given the severe hyperglycemia, review injection technique immediately 2:

  • Rotate within one area systematically (e.g., rotating within abdomen) rather than rotating to different areas 2
  • Abdomen has fastest absorption rate, followed by arms, thighs, buttocks 2
  • Check for lipohypertrophy - areas of lipohypertrophy show slower absorption 2
  • Ensure proper subcutaneous injection - intramuscular injection not recommended for routine use 2

Timeline for Reassessment

  • Adjust basal insulin every 3 days based on fasting glucose patterns 1
  • Adjust prandial insulin every 3 days based on postprandial glucose readings 1
  • Clinical follow-up in 2-4 weeks to assess progress and adherence 1
  • HbA1c recheck in 3 months to determine if additional intensification needed 1

References

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Intensification for Patients with Elevated A1c

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What adjustments can be made to minimize hypoglycemia risk in a patient on Humalog (insulin lispro) and Lantus (insulin glargine) with good glycemic control?
How should therapy be adjusted for a patient with uncontrolled diabetes, on a sliding scale regimen with Humalog (insulin lispro) and 30 units of Lantus (insulin glargine) at bedtime, with a hemoglobin A1c (HbA1c) level of 10.7%?
What is the recommended NPH dose for a patient on Lantus (insulin glargine) and prednisone, without carb counting?
For an elderly male patient with diabetes, taking Basaglar (insulin glargine) 34 units per day, Lispro (insulin lispro) 6 units three times a day, and Ozempic (semaglutide) once a week, with a Hemoglobin A1c (HbA1c) level of 6.9%, should Lispro be discontinued and an oral medication started instead?
What medication dose should be increased in a patient with HbA1c 8.5% on Soligua (insulin glargine) 30 units, Lyumjev (insulin lispro-aabc) 12 units TID, and Jardiance (empagliflozin) 10 mg to improve glycemic control?
What is the best approach to manage a patient with cognitive impairment, presenting with delusions, paranoia, over familiarity, and occasional elated mood, considering a background of possible dementia or mild cognitive impairment?
What type of Parkinson's disease is correlated with mild to moderate asymmetrically reduced tracer concentration in the left frontal, temporal, and parietal regions, anterior cingulate gyrus, bilateral (b/l) thalami, and cerebellar regions on a Positron Emission Tomography (PET) Computed Tomography (CT) scan in a patient likely over 60 years old?
What is dilution in the context of Human Immunodeficiency Virus (HIV) transmission, particularly regarding pre-ejaculate on fingers during digital penetration?
What is the best course of treatment for a patient with left lower back pain that is tender to palpation?
Can you diagnose my condition based on my spine X-ray?
What should I do about my persistent migraine that has lasted for 15 days, worsened by light and movement, despite staying hydrated and taking Excedrin (acetaminophen, aspirin, and caffeine)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.